Status:
COMPLETED
KF STRIDE to Improve Job Interview Skills
Lead Sponsor:
Kessler Foundation
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
14-26 years
Phase:
NA
Brief Summary
The goals of the current study are to evaluate the preliminary effectiveness and feasibility of Kessler Foundation-Strength Identification and Expression (KF-STRIDE) in an 8-week randomized controlled...
Detailed Description
This study will evaluate the acceptability and effectiveness of a strength-based intervention (Kessler Foundation Strength Identification and Expression; KF-STRIDE) that can enhance job interview skil...
Eligibility Criteria
Inclusion
- adolescents with Autism Spectrum Disorder
- Live in the United States of America
- Ages of 14-26
- Speak English fluently and at a 4th grade reading level
Exclusion
- History of stroke, Traumatic Brain Injury, or neurological injury or disease in the past (like brain tumor or epilepsy).
- History of significant psychiatric illness
- Uncontrolled seizures or other unstable medical complications.
Key Trial Info
Start Date :
March 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 12 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04820647
Start Date
March 29 2021
End Date
January 12 2024
Last Update
March 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kessler Foundation
East Hanover, New Jersey, United States, 07936